移植医療基盤整備研究事業

(○:委員長)
  相川 厚 東邦大学 名誉教授
  腎移植、腎臓学、泌尿器科学
  <研究論文例1>
Outcomes of Pediatric ABO-incompatible Living Kidney Transplantations From 2002 to 2015: An Analysis of the Japanese Kidney Transplant Registry.Hattori M, Mieno M, Shishido S, Aikawa A, Ushigome H, Ohshima S, Takahashi K, Hasegawa A; Japan Society for Transplantation and Japanese Society for Clinical Renal Transplantation.Transplantation. 2018;102(11):1934-1942.
  <研究論文例2>
ABO incompatible kidney transplantation --immunological aspect-.Aikawa A, Yamashita M, Hadano T, Ohara T, Arai K, Kawamura T, Hasegawa A.Exp Clin Transplant. 2003;1(2):112-118
  <研究論文3>
Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.Itabashi Y, Aikawa A, Muramatsu M, Hyoudou Y, Shinoda K, Takahashi Y, Sakurabayashi K, Mizutani T, Oguchi H, Arai T, Kawamura T, Hamasaki Y, Sakai K, Shishido S.Exp Clin Transplant. 2019;17(Suppl 1):43-49
       
 
 
  江川 裕人 浜松労災病院 院長
  臓器移植
  <研究論文>
362.   Egawa H, Ohdan H, Saito K.Current Status of ABO-incompatible Liver Transplantation. Transplantation. 2023 Feb 1;107(2):313-325. doi: 10.1097/TP.0000000000004250. Epub 2022 Jul 11. PMID: 35849558
  <著作例>
「必携 内科医のための臓器移植診療ハンドブック」一般社団法人  日本移植学会 Transplant Physician委員会編集,パーソン書房、(ISBN 978-4/907095-79-6)(2023)
AMED江川班成果物
  <学術的発表例>
Bnt162b2 Vs. Mrna1273 In Solid Organ Transplant Recipients: Propensity Score Analysis Of Japanese National Cohort Study Egawa H, Annual Congress of ILTS 2023
       
 
 
  大橋 一輝 東京都立多摩総合医療センター 副院長
  血液学 造血幹細胞移植
  Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation. Kurosawa S, Doki N, Senoo Y, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Yoshifuji K, Matsuyama N, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Ann Hematol. 2020 Aug; 99(8): 1873-82.
  Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT. Najima Y, Sadato D, Harada Y, Oboki K, Hirama C, Toya T, Doki N, Haraguchi K, Yoshifuji K, Akiyama M, Inamoto K, Igarashi A, Kobayashi T, Kakihana K, Okuyama Y, Sakamaki H, Harada H,Bone Marrow Transplant. 2021 Feb; 56(2): 334-46.
 
  Prognostic factors for outcomes of allogeneic HSCT for children and adolescents/young adults with CML in the TKI era.Shimada H, Tanizawa A, Kondo T, Nagamura-Inoue T, Yasui M, Tojo A, Muramatsu H, Eto T, Doki N, Tanaka M, Sato M, Noguchi M, Uchida N, Takahashi Y, Sakata N, Ichinohe T, Hashii Y, Kato K, Atsuta Y, Ohashi K; Pediatric and adult CML/MPN working groups of the Japanese society for transplantation and cellular therapy. Transplant Cell Ther. 2022 Jul; 28(7): 376-89.
 
       
 
 
島崎 修次 国士舘大学 防災救急救助総合研究所 所長
  救急医学
  「脳死下臓器提供102例の検証―救命治療,脳死判定にかかわる状況― 特集:脳死下臓器提供例の検証と検証システム」島崎修次他共著,移植(一般社団法人 日本移植学科会),48(2-3),84-88,(2013.06)
  Ⅱ.組織移植と日本組織移植学会(JSTT)
Ⅲ.日本組織移植学会の活動
 :組織移植TextBook島崎修次,田中秀治
へるす出版(2018)
  「「脳死は死」という日本救急医学会の提言をまとめるにあたって」島崎修次他共著,移植(一般社団法人 日本移植学科会),44(特別号),35-38,(2009.10)
       
 
 
  山口 照英 日本薬科大学 客員教授 
  細胞生物学
  Occludin as a functional marker of vascular endothelial cells on tube-forming activity. Toshie Kanayasu-Toyoda, Akiko Ishii-Watabe, Yutaka Kikuchi, Hiroko Kitagawa, Hiroko Suzuki, Hiroomi Tamura, Minoru Tada, Takuo Suzuki, Hiroyuki Mizuguchi, Teruhide Yamaguchi J Cell Physiol. 2018 Feb;233(2):1700-1711.
  Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan. Teruhide Yamaguchi, Eriko Uchida, Takashi Okada, Keiya Ozawa, Masafumi Onodera, Akihiro Kume, Takashi Shimada, Satoru Takahashi, Kenzaburo Tani, Yasutomo Nasu, Tomoji Mashimo, Hiroyuki Mizuguchi, Kohnosuke Mitani, and Kazushige Maki Human Gene Therapy. 2020 Oct;31(19-20).
  Cell-Surface MMP-9 Protein Is a Novel Functional Marker to Identify and Separate Proangiogenic Cells from Early Endothelial Progenitor Cells Derived from CD133(+) Cells. Toshie Kanayasu-Toyoda, Takeshi Tanaka, Yutaka Kikuchi, Eriko Uchida, Akifumi Matsuyama, Teruhide Yamaguchi. Stem Cells. 2016 May;34(5):1251-62.